Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarvnaz Sadrameli
Institutions:
University of Chicago,
University of Chicago Medical Center
Observed institutions:
University Health System,
University of Illinois Chicago,
University of Chicago,
University of Chicago Medical Center,
The University of Texas at Austin
ORCID:
0000-0002-7435-3090
Observed ORCID:
0000-0002-7435-3090
OpenAlex ID:
A5033765000
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update
2020
·
Kirk E. Evoy
, Sarvnaz Sadrameli
, et al.
·
Drugs
·
302
Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
2021
·
Kirk E. Evoy
, Sarvnaz Sadrameli
, et al.
·
Drugs
·
6
Utility of Thrombopoietin Receptor Agonists for Prolonged Thrombocytopenia After Chimeric Antigen Receptor T-cell Therapy
2025
·
Donald Waddell
, Jennifer Collins
, et al.
·
Transplantation and Cellular Therapy
·
5
Tolerability Assessment of Tyrosine Kinase Inhibitors in Patients With Solid Tumor Malignancies and Hypoalbuminemia
2024
·
Sarvnaz Sadrameli
, Sydney Bringgold
, et al.
·
Annals of Pharmacotherapy
·
2
PDF
Time toxicity in previously untreated metastatic or unresectable epidermal growth factor receptor-mutant non-small cell lung cancer: a clinical practice review
2025
·
Won Jin Jeon
, Bowon Joung
, et al.
·
Translational Lung Cancer Research
·
1
Show more works
View as search
Works count:
5
Citation count:
316
H-index:
3
I10-index:
1
Year
Topic
Type